Cyxtera Results Presentation Deck
Q2 YTD 2022
Results
Core revenue increased by $19.1 million, or 6.1%, YoY to $168.8 million
Transaction Adjusted EBITDA of $118.5 million was flat year-over-year,
principally due to higher revenue partially offset by higher SG&A costs
Cyxtera
($ in Millions)
Recurring Revenue
Non-Recurring Revenue
Total Revenue
Cost of Revenue
As a % of Revenue
Gross Profit
% Margin
Total SG&A
As a % of Revenue
Other (1)
EBITDA
% Margin
Transaction Adjustments
Transaction Adjusted EBITDA (²)
% Margin
Rent (net of adjustments)
Transaction Adjusted EBITDAR (3)
% Margin
Capital Expenditures
As a % of Revenue
Q2 YTD
2022
$347.8
18.7
$366.5
$196.4
53.6%
$170.1
46.4%
$66.0
18.0%
($9.2)
$113.3
30.9%
$5.2
$118.5
32.3%
$30.6
$149.1
40.7%
$64.4
17.6%
Q2 YTD
2021
$332.0
16.3
$348.3
(1) Q2 22 YTD includes ($11.8M) benefit related to change in fair value of derivative liabilities, offset by $2.6M in restructuring, impairment, site closures and related cost. Q2 21 YTD includes $67.0M in restructuring, impairment, site closures and related cost
(2) Earnings Before Interest, Taxes, Depreciation, Amortization;
(3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent;
$193.9
55.7%
$154.4
44.3%
$50.5
14.5%
$67.0
$36.9
10.6%
$81.4
$118.4
34.0%
$30.3
$148.7
42.7%
$27.0
7.8%
YOY Change
4.8%
14.3%
5.2%
1.3%
(207 bps)
10.1%
207 bps
30.7%
351 bps
ΝΑ
206.8%
2,031 bps
0.1%
(164 bps)
0.3%
(201 bps)
138.4%
981 bps
12View entire presentation